COVID-19 in pregnancy-characteristics and outcomes of pregnant women admitted to hospital because of SARS-CoV-2 infection in the Nordic countries. by Engjom, Hilde et al.
Acta Obstet Gynecol Scand. 2021;100:1611–1619.   | 1611wileyonlinelibrary.com/journal/aogs
Received: 28 January 2021  | Revised: 29 March 2021  | Accepted: 6 April 2021
DOI: 10.1111/aogs.14160  
O R I G I N A L  R E S E A R C H  A R T I C L E
COVID- 19 in pregnancy— characteristics and outcomes of 
pregnant women admitted to hospital because of SARS- CoV- 2 
infection in the Nordic countries
Hilde Engjom1,2*  |   Anna J.M. Aabakke3,4*  |   Kari Klungsøyr5,6 |   Teresia Svanvik7 |   
Outi Äyräs8 |   Eva Jonasdottir9 |   Lars Thurn10 |   Elin Jones11 |   Karin Pettersson11 |   
Lill T. Nyfløt12 |   Iqbal Al- Zirqi12  |   Siri Vangen12  |   Pétur B. Júlíusson1 |   
Karin Källén13  |   Mika Gissler14 |   Lone Krebs4,15
1Department of Health Registry Research and Development, Norwegian Institute of Public Health, Bergen, Norway
2Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, Norway
3Department of Obstetrics and Gynecology, Copenhagen University Hospital – Holbæk, Holbæk, Denmark
4Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
5Department of Global Public Health and Primary Care, University of Bergen, Norway
6Division of Mental and Physical Health, Norwegian Institute of Public Health, Norway
7Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden
8Department of Obstetrics and Gynecology, Helsinki University Hospital, Helsinki, Finland
9Department of Obstetrics and Gynecology, Landspitali University Hospital, Reykjavik, Iceland
10Department of Obstetrics and Gynecology, Skåne University Hospital, Lund, Sweden
11Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden
12Norwegian Research Center for Womens’ Health, Oslo University Hospital, Oslo, Norway
13Institution of Clinical Sciences, Department of Obstetrics and Gynecology, Lund University, Lund, Sweden
14The Finnish Institute of Health and Welfare, Helsinki, Finland
15Department of Obstetrics and Gynecology, Copenhagen University Hospital – Amager and Hvidovre, Copenhagen, Denmark
This is an open access article under the terms of the Creative Commons Attribution- NonCommercial- NoDerivs License, which permits use and distribution in 
any medium, provided the original work is properly cited, the use is non- commercial and no modifications or adaptations are made.
© 2021 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of 
Obstetrics and Gynecology (NFOG).
*Shared first authorship.
Abbreviations: BMI, body mass index; CD, cesarean delivery; COVID- 19, SARS- CoV- 2 disease with symptoms; ICU, intensive care unit; Iceland, Iceland; INOSS, International Network of Obstetric 
Survey Systems; MBRN, Medical Birth Registry of Norway; NICU, Neonatal Intensive Care Unit; NIPH, Norwegian Institute of Public Health; NOSS, Nordic Obstetric Surveillance Study.
Correspondence
Hilde Engjom, The Norwegian Institute 
of Public Health, Bergen, Norway and 





The clinical trial management software 
EASYTRIAL, used for data management 
in Denmark, was provided for free for 
this study, as the company offered free 
access to the software to COVID- 19 
research projects. The Nordic Federation 
Abstract
Introduction: Population- based studies about the consequences of SARS- CoV- 2 
infection (COVID- 19) in pregnancy are few and have limited generalizability to the 
Nordic population and healthcare systems.
Material and methods: This study examines pregnant women with COVID- 19 in 
the five Nordic countries. Pregnant women were included if they were admitted to 
hospital between 1 March and 30 June 2020 and had a positive SARS- CoV- 2 PCR 
test ≤14 days prior to admission. Cause of admission was classified as obstetric or 
COVID- 19- related.
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1  |  INTRODUC TION
The World Health Organization declared a global pandemic of 
coronavirus disease in March 2020.1 During the H1N1 influenza 
pandemic, pregnant women were particularly vulnerable, result-
ing in increases of maternal and perinatal mortality among those 
infected.2- 8 Systematic review and meta- analysis by WHO about 
the effect of COVID- 19 in pregnancy identified preexisting comor-
bidities and high maternal age and body mass index (BMI) as risk 
factors for severe infection.9 Preterm birth rate increased among 
infected women.9 Recent publications from the USA indicate that 
pregnant women are at higher risk for serious COVID- 19 disease 
compared with non- pregnant women.10,11 These studies and the 
majority of studies in the WHO systematic review were performed 
in settings with limited generalizability to the Nordic populations 
and healthcare systems. With the on- going pandemic, population- 
based studies with larger case numbers and lower risk of bias are 
crucial for guiding disease surveillance and health management.12 A 
few population- based studies assessing the risk and consequences 
of COVID- 19 infection in pregnancy have been published.13- 15 
However, the inclusion criteria comprised all causes of hospital ad-
mission, resulting in heterogeneous study populations.
The population in the Nordic countries is relatively uniform, 
and healthcare during pregnancy is provided free of charge. All five 
countries have medical birth registries with mandatory registrations 
of maternal and fetal/neonatal outcomes of all births.
The objective of this study was to describe hospital admissions 
of pregnant women with COVID- 19 in the Nordic countries. We 
present preliminary, aggregated results including the characteris-
tics and medical risk factors, clinical management and outcomes of 
pregnant women with COVID- 19, focusing primarily on the group of 
women admitted due to COVID- 19, during the first 4 months of the 
pandemic in the Nordic countries.
2  |  MATERIAL AND METHODS
This study is an ongoing prospective observational study in the 
Nordic countries and part of the Nordic Obstetric Surveillance Study 
(NOSS) collaboration. The study includes pregnant women with 
COVID- 19 infection and hospital admission for at least 24 hours. 
COVID- 19 infection was defined as detection of viral RNA on a phar-
yngeal swab ≤14 days prior to hospital admission. Cause of admis-
sion was classified as obstetric, for example, delivery or obstetric 
complaints, or COVID- 19- related.
Primary outcomes included maternal or neonatal admission to 
intensive care unit (ICU or NICU), COVID- 19 pneumonia, maternal 
of Societies of Obstetrics and Gynecology 
(NFOG) granted financial support 
to the planning, data collection and 
communication of results from this 
project.
Results: In the study areas, 214 pregnant women with a positive test were admitted to 
hospital, of which 56 women required hospital care due to COVID- 19. The risk of ad-
mission due to COVID- 19 was 0.4/1000 deliveries in Denmark, Finland and Norway, 
and 3.8/1000 deliveries in the Swedish regions. Women hospitalized because of 
COVID- 19 were more frequently obese (p < 0.001) and had a migrant background 
(p < 0.001) compared with the total population of women who delivered in 2018. 
Twelve women (21.4%) needed intensive care. Among the 56 women admitted due to 
COVID- 19, 48 women delivered 51 infants. Preterm delivery (n = 12, 25%, p < 0.001) 
and cesarean delivery (n = 21, 43.8%, p < 0.001) were more frequent in women with 
COVID- 19 compared with women who delivered in 2018. No maternal deaths, still-
births or neonatal deaths were reported.
Conclusions: The risk of admission due to COVID- 19 disease in pregnancy was low in the 
Nordic countries. A fifth of the women required intensive care and we observed higher 
rates of preterm and cesarean deliveries. National public health policies appear to have 
had an impact on the risk of admission due to severe COVID- 19 disease in pregnancy. 
Nordic collaboration is important in collecting robust data and assessing rare outcomes.
K E Y W O R D S
cohort studies, COVID- 19, obstetric delivery, pregnancy, pregnancy complications, pregnancy 
outcome, prospective studies, severe acute respiratory syndrome coronavirus 2
Key message
Risk of hospital admission due to COVID- 19 infection 
among pregnant women was low in the Nordic countries, 
but varied between the countries, most likely related to 
different national public health strategies.
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mortality (deaths during pregnancy or within 42 days after the end 
of pregnancy), preterm delivery (delivery before 37 completed 
weeks of gestation) and perinatal mortality (stillbirth from 22 com-
pleted weeks of gestation and first week neonatal deaths). We 
collected information on sociodemographic risk factors (partner 
status, migrant background, occupation), pregestational chronic 
diseases (including cardiac, renal, endocrine, psychiatric, hemato-
logic and autoimmune disease, cancer and HIV), gestational age at 
COVID- 19 infection, and clinical care such as induction of labor and 
mode of delivery.
Calculation of BMI was based on pregestational weight or first 
recorded weight in pregnancy. Gestational age was based on es-
timated date of delivery assessed by ultrasound according to na-
tional guidelines, or according to last menstrual period for women 
without an ultrasound dated pregnancy at the time of COVID- 19 
infection.
Data were entered into a uniform case report form, adapted in 
each country.
In Denmark, all obstetric units participated. A clinician in each 
unit prospectively reported cases to a joint electronic database in 
EASYTRIAL (easytrial.net, Denmark). Reminders were sent out to 
secure data completeness and cases were validated by a retrospec-
tive registry linkage, with data obtained from the Danish National 
Patient Register, the Danish National Service Register and the 
Danish Microbiology Database every second month. Missing cases 
identified by validation were entered retrospectively.
In Finland, cases admitted to Helsinki University Hospital were 
included. Most of the COVID- 19 patients in Finland during the study 
period were inhabitants of the Helsinki region (73%, n = 19), and 
fewer than three cases were reported to have been admitted to the 
other university hospitals by November 2020 (O Äyräs pers. corres.). 
Consequently, data collection from Helsinki University Hospital 
alone is assumed to have included most affected cases. Data were 
entered into the report form by one primary investigator.
In Iceland, public health authorities recorded all cases of COVID- 19, 
and information about all pregnant women with COVID- 19 was for-
warded to the Icelandic Birth Registry. Cases were validated by a 
retrospective registry linkage with data obtained from the Icelandic 
National Patient Register and the Icelandic Birth Register. Data were 
entered into the report form by one primary investigator.
In Norway, data were prospectively collected by the Medical 
Birth Registry of Norway (MBRN) at the Norwegian Institute of Public 
Health (NIPH). All hospitals providing care for pregnant women par-
ticipated. Reminders were sent out bimonthly. Data were entered 
using an online form to a safe research server at Service for Sensitive 
Data (TSD), University of Oslo, contracted by MBRN/NIPH.
In Sweden, data were included from three institutions: 
Karolinska University Hospital (KUH), Sahlgrenska University 
Hospital (SaUH) and Skåne University Hospital (SkUH). These insti-
tutions are among the major referral hospitals in the country and 
account for 22% of annual deliveries in Sweden. Data were retrieved 
from Hospital Discharge Registers and medical records at each 
participating obstetric unit and entered into a joint electronic data-
base in REDCap16,17 hosted at Lund University.
The study sample size was governed by the disease incidence, so 
no formal power calculation was performed.
Results are reported both for all five countries and but are re-
stricted to Denmark, Finland, Iceland and Norway to account for 
potential selection bias in the Swedish data, where only tertiary 
centers were included. Nominal data are presented as numbers and 
percentages. Continuous variables are presented as the range of 
country means when normally distributed and when not normally 
distributed as range of country medians. Comparison data for all de-
liveries in 2018, the most recent year for which complete data were 
available, were collected from the national Medical Birth Registry 
websites,18- 21 and using unpublished statistics provided by the reg-
istries. The total number of deliveries was based on the number of 
deliveries during the study period in Norway and at the included 
Swedish sites, and an estimation based on the number of annual de-
liveries in 2019 in Denmark, Finland and Iceland. Chi- square tests 
were used to assess differences in outcome frequencies between 
the cases and the comparison population.
Data analyses were performed using IBM SPSS Statistics 21 
(IBM Corp., Armonk, NY, USA) and STATA 16SE (STATA CORP LLC, 
College Station, TX, USA).
2.1  |  Ethical approval
National ethical approval was obtained from the following 
authorities:
Denmark: Danish Patient Safety Authority (reg. no. 31– 1521– 
252: 24 April 2020) and the regional Data Protection Agency in 
Region Zealand (reg. no. REG- 022– 2020: 23 March 2020)
Finland: Helsinki University Hospital. (reg. no. HUS1624/2020: 
13 May 2020)
Iceland: Landspitali University Hospital, the National Bioethics 
Committee (reg. no. VSNb2020050016/03.0I: 25 June 2020) and 
the Icelandic Data Protection Authority (reg. no. 20– 106: 9 June 
2020)
Norway: Norwegian Institute of Public Health, Data, Protection 
Officer (reg. no. 20_11054: 3 April 2020) and the Western Regional 
Ethics Committee (reg. no. 125890: 26 March 2020)
Sweden: the Swedish Ethical Review Authority (reg. no. 2020– 
03012: 11 August 2020 for SUH and SKH and reg. no. 2020– 01499: 
22 April 2020 for KUH).
In Denmark, Iceland, Norway and KUH, ethical approval ex-
cluded the studies on the principle of individual consent. In Finland, 
ethical approval is not required in register- based studies. In SaUH 
and SkUH, women received written information about the study, in-
cluding an opt- out possibility. Data were managed and stored in ac-
cordance with national regulations and the General Data Protection 
Regulation (GDPR). National numbers <3 are not presented to avoid 
identification.
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3  |  RESULTS
Between 1 March and 30 June 2020, we identified 214 pregnant 
women who were admitted to hospital for any reason with a posi-
tive SARS- CoV- 2 PCR test ≤14 days prior to hospital admission. No 
women opted out in Sweden. The risk of hospital admission was 
0.8/1000 deliveries, ranging from 0.5 to 1.0/1000 in Denmark, 
Finland, Iceland and Norway, and 18.2/1000 in the Swedish regions.
Due to different national and regional testing strategies (Table S1) 
the study groups in the various countries were heterogeneous, with 
more women with asymptomatic/mild COVID- 19 admitted for de-
livery or obstetric care in countries/regions with universal screen-
ing. Characteristics of women admitted for any reason are shown in 
Table S2. We therefore restricted further analyses to the pregnant 
women who required hospital admission because of COVID- 19 dis-
ease, as shown in the flowchart (Figure 1).
Fifty- six pregnant women required hospital care for COVID- 19 
disease. There were no admissions in Iceland and the risk of hospi-
tal admission was 0.4/1000 deliveries (range 0.3– 0.5) in Denmark, 
Finland and Norway, and 3.8/1000 in the Swedish regions.
Figure 2 illustrates the gestational age at first positive SARS- 
CoV- 2 test among the included women. Most women admitted due 
to COVID- 19 were in the third trimester of pregnancy when they 
tested positive. Figure S2 shows the month of first positive test and 
thus illustrates the pandemic timeline.
Characteristics of the pregnant women admitted due to 
COVID- 19 are presented together with the Medical Birth Registry 
data from 2018 in Table 1. Compared with the women who delivered 
in 2018, women admitted due to COVID- 19 were more frequently 
obese, had BMI >30 (p < 0.001) and were migrants (p < 0.001).
In the Swedish regions, relatively more women admitted due 
to COVID- 19 had preexisting chronic diseases compared with 
the other Nordic countries (Sweden: n = 14/36; 38.9%, Denmark, 
Finland, Iceland, Norway: n = 2/20; 10%). The Swedish women had 
positive SARS- CoV- 2 tests later in pregnancy and therefore also had 
a shorter interval between test and delivery.
The maternal and fetal/neonatal outcomes and clinical care are 
presented in Table 2. Among the 56 cases, 12 women were admit-
ted to ICU (21.4%). No maternal deaths were reported. During the 
study period, 48 women delivered 51 infants. Compared with 2018 
deliveries, more women admitted due to COVID- 19 had a cesarean 
delivery (CD) (41.7 vs 17.3%, p < 0.001), and the proportion of emer-
gency CD was higher (85.0 vs 53.8%, p = 0.003). The risk of preterm 
delivery was also increased (25% vs 5.7%, p < 0.001). Seven neo-
nates were admitted to NICU (13.7%) and no stillbirths or neonatal 
deaths were reported.
In the Swedish regions, induction of labor among the COVID- 19 
infected women was more frequent than in the other Nordic coun-
tries (Sweden: n = 11/31, 35.5%; Denmark, Finland, Iceland, Norway: 
n = 5/17, 29.4%) but fewer women had a CD (Sweden: n = 12/31, 
38.7%; Denmark, Finland, Iceland, Norway: n = 9/17; 52.9%).
F I G U R E  1  Flow diagram 
Total deliveries
1. March – 30. June 2020
(n ≈ 64 694)
Delivered
(n = 48)
Admitted because of 
COVID-19
(n = 56)
Admitted for obstetric 
care/labor
(n = 158)




Pregnant women admitted to 









F I G U R E  2  Completed gestational week 
at first positive SARS- CoV- 2 PCR test in 
56 pregnant women admitted to hospital 
due to COVID- 19 in the Nordic countries 
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4  |  DISCUSSION
This prospective study in the five Nordic countries showed a low 
risk of hospital admission due to COVID- 19 among pregnant women. 
Pregnant women hospitalized due to COVID- 19 infection were more 
often obese and more likely to have a migrant background than were 
women who delivered in 2018. Hospitalization due to COVID- 19 was 
associated with an increased risk of delivering preterm and by cesarean.
We included only women admitted to hospital due to COVID- 19 
symptoms in the final analyses and excluded women admitted for 
obstetric reasons, resulting in a study population less influenced by 
the national testing strategies. These strategies varied over time and 
between countries during the inclusion period (Figure S1) and could 
have biased the study results otherwise.
Large population- based cohort studies from the UK and Italy 
found an incidence of hospitalization with COVID- 19 of 2– 4.9/1000 
maternities,13- 15 which is much higher than the risk of 0.4/1000 de-
liveries found in Denmark, Finland, Iceland and Norway. However, 
those studies included admissions for any reason, such as obstetric 
care and labor. Further, our Nordic study was restricted to women 
with present infection with a limitation of 14 days between test and 
admission. Nevertheless, even if all admissions were included in the 
Nordic countries, the admission risk in Denmark, Finland, Iceland 
and Norway of 0.8/1000 deliveries was lower than in Italy and the 
UK. Additionally, the risk of admission was considerably higher in the 
Swedish regions, which may reflect higher population infection rates 
and also selection bias, with higher admission rates at university hos-
pitals. The risk of hospital and intensive care admissions in the total 
population was also higher in Sweden than in the other Nordic coun-
tries. This may indicate that policies reducing the transmission in the 
general population also reduce the risk of hospital admission due to 
COVID- 19 among pregnant women.
Among pregnant women admitted with COVID- 19 in the Nordic 
countries, obesity and migrant background were more common than 
in the 2018 birth population, corresponding to the findings of previ-
ous studies.9,13,14 This information is relevant when developing na-
tional public health strategies.
In the Nordic countries, no maternal, fetal or neonatal deaths 
were registered among the pregnant women admitted due to 
COVID- 19 during the first 4 months of the pandemic. However, 
21% of the women needed intensive care, which is higher than the 
proportion in previous population- based studies from UK, Italy and 
the Netherlands,13,14,23 reflecting our inclusion of only the most se-
vere cases. Previous Swedish and Dutch studies found that pregnant 
women with COVID- 19 had a higher risk of ICU admission compared 
with non- pregnant women of the same age with COVID- 19.23,24
Induction of labor, preterm delivery, CD and emergency CD were 
more frequent among women admitted due to COVID- 19 compared 
with the 2018 birth population, which corresponds to previous find-
ings.9,13,23 An increasing risk of preterm delivery and CD with increas-
ing severity of COVID- 19 has also been reported.14 A previous study 
from one of the including Swedish centers found no increased risk 
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women independently of severity or presence of symptoms, which 
might have biased their results.
Compared with the other Nordic countries, more women ad-
mitted to the included hospitals in Sweden had other chronic dis-
eases, which possibly reflects selection bias by inclusion of cases 
from tertiary care hospitals only. One of the three centers in 
Sweden implemented universal testing of all obstetric admissions 
during the inclusion period (Table S1). This is reflected in the higher 
gestational age at first SARS- CoV- 2 test and the shorter inter-
val between test and delivery, since relatively more women with 
scarce symptoms screened positive upon admission for delivery. 
Further, fewer women in Sweden than in the other Nordic coun-
tries delivered preterm or had a CD, and fewer infants required 
neonatal care, which reflects the identification of only the most 
severe cases in the other countries, where different testing strat-
egies were applied.
This study has several strengths. Compared with previous studies, 
the inclusion of a homogeneous group of pregnant women admitted 
to hospital because of COVID- 19 infection and with a positive test 
within 14 days of admission, strengthens the assessment of outcomes 
and controls for variation in testing strategies between the countries. 
Further, the data were prospectively recorded in medical records and 
later retrieved, and all reported cases were verified with patient re-
cords. Additionally, this study assesses the consequences of COVID- 19 
by using a comparison group not affected by a pandemic. The Nordic 
collaboration between several countries with relatively uniform popu-
lations provides a larger cohort than would national studies alone, pro-
viding relevant data to Nordic and international healthcare providers.
This study also has several limitations. We only reported out-
comes for women admitted due to COVID- 19 and can therefore not 
draw conclusions about COVID- 19 infection among pregnant women 
in general. Additionally, the aggregate data currently available did 
not allow for assessment of individual risk factors and mediating 
factors. Prospective reporting could potentially cause underreport-
ing of cases by lack of identification. Assessment of completeness 
by linkage to the National Infectious Disease and the Medical Birth 
Registry was done in Denmark and Iceland, but was not yet possible 
in the other countries. However, the number of cases in Denmark 
was comparable to numbers in Finland, Iceland and Norway, where 
testing strategies were similar, indicating that most cases were 
identified. The Swedish data represent three large tertiary centers, 
equivalent to 22% of the annual deliveries in Sweden, and there is 
a potential risk for both underreporting and selection bias in the 
Sweden data. We therefore presented data for all countries com-
bined and for Denmark, Iceland, Finland and Norway alone.
We did not have concurrent data for non- infected pregnancies 
available for comparison at the time of publication. We therefore re-
late the results to 2018 data not influenced by the pandemic, which 
may be viewed as an advantage. However, the NOSS COVID- 19 
group plans to analyze data against population data for 2020 when it 
is released from the Nordic Medical Birth Registries.
Studies similar to the NOSS COVID- 19 collaboration are taking 
place in several countries worldwide as part of the International 
Network of Obstetric Survey Systems (INOSS).25 Uniform inter-
national population- based studies are needed to reduce potential 
selection bias in institution- based studies. Combining data interna-
tionally will allow assessment of rare, severe complications and risk 
factors, and aid in the understanding of the disease in pregnancy 
even better.
5  |  CONCLUSION
This multinational Nordic study showed a low risk of admission due 
to COVID- 19 in pregnancy in the Nordic countries. Women admit-
ted to hospital due to COVID- 19 were more frequently obese or had 
a migrant background compared with non- infected women. A fifth 
of the admitted women required intensive care and we observed 
higher risks of preterm and cesarean deliveries than among deliver-
ies in 2018. The study indicates that the risk of admission and com-
plications in pregnancy related to COVID- 19 may be associated with 
national public health measures to reduce transmission of disease.
The Nordic collaboration is important in collecting robust data 
and may provide future benefits in the analysis of rare obstetric out-
comes in pandemic responses.
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